- Home
- Genex
More Stories by This Author
StateWatch: Bill Review April 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
StateWatch: Bill Review March 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
StateWatch: Early Spring 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the services Genex provides.
WC Magazine: Putting Out Fires
StateWatch: Early Spring 2018
The FDA recently approved a new opioid prodrug, Apadaz (benzhydrocodone and acetaminophen). The oral tablets are designed for short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
New Workers' Compensation Review Contractor
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the Medicare Set-Aside services Genex provides.